Our findings suggest that GZMK, TREM2, and OR4D10 may play important roles in modulating the immune response in thyroid cancer, potentially through their effects on leukocyte cell–cell adhesion and mononuclear cell differentiation. Here, TREM2 is linked to thyroid gland carcinoma.